3T Ophthalmics
3T Ophthalmics, based in Irvine, California, focuses on the development of innovative, less invasive ocular drug delivery systems designed to target therapeutic agents for various ocular diseases. Their proprietary technology allows for the delivery of treatments without penetrating the eye, addressing conditions such as neoplastic, inflammatory, neovascular, and neurodegenerative diseases.
Recognized for their advancements in treating Retinoblastoma, a pediatric ocular cancer, 3T Ophthalmics received Breakthrough Therapy Designation from the FDA for their lead product, Episcleral Topotecan. This designation reflects the product's potential to significantly improve treatment outcomes for patients, showcasing a commitment to enhancing therapies and restoring vision.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.
Partial Data by Foursquare.